Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 15.71
+0.03 (0.19%)
Apr 25, 2025, 2:45 PM CST
Hualan Biological Vaccine Company Description
Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China.
It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, influenza A (H1N1) virus split vaccines, ACYW135 group meningococcal polysaccharide vaccines, recombinant hepatitis B vaccines, group A and C meningococcal polysaccharide vaccines, freeze-dried human rabies vaccine, and tetanus vaccines, as well as genetic engineering of biological products.
The company also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Hualan Biological Vaccine Inc.
| Country | China |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 748 |
| CEO | Wenjue An |
Contact Details
Address: Jia No. 1-1, Hualan Avenue Xinxiang, 453003 China | |
| Phone | 86 37 3355 9991 |
| Website | hualanbacterin.com |
Stock Details
| Ticker Symbol | 301207 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000058J9 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wenjue An | GM and Director |
| Ruowen Pan | Executive Vice President and Director |